jeudi 23 mars 2017

Onco Actu du 23 mars 2017

3.1 Tabac

Global smoking rates have fallen since introduction of international tobacco control strategy [Cancer Research UK]

3.4 Chimioprévention

Postmenopausal women with a family history of breast cancer should be offered anastrozole, says NICE in updated guidance [NICE]

NICE backs use of drugs for breast cancer prevention [PharmaTimes]

5.2 Pharma

Striving to vanquish leukemia [Novartis]

5.2.1 Pharma - Partenariats

GSK and Regeneron to mine gene data from 500,000 Britons [Reuters]

5.2.3 Pharma - économie

BioClin raises $30M Series B round for bladder cancer candidate [FierceBiotech]

BioClin Gets $30M to Back More Bladder Cancer Drug Trials [Xconomy]

BioClin scores a $30M raise from marquee investors to fuel mid-stage work on a new cancer drug [EndPoints]

Three considerations for the pharma industry as President Trump focuses on drug pricing [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

Call for experts in anonymisation of clinical data [EMA]

5.4 Traitements - Economie

Cost effective but unaffordable: an emerging challenge for health systems [BMJ]

6. Lutte contre les cancers

U.S. Cancer Care System Poised for Transformation, but Challenges Loom Large [ASCO]

6.1 Observation

The pill provides 'lifelong protection against some cancers' [NHS Choices]

6.10.1 Politiques (USA)

Slashing the NIH budget won’t keep America first in the fight against cancer [STAT]

The Need for Publicly Funded Science [Neurologica]

6.12 Ethique

With patients demanding experimental drugs, ‘right to try’ is becoming the law of the land [STAT]

6.2 Implants mammaires

Breast Implants Linked To Rare Blood Cancer In Small Proportion Of Women [NPR]

FDA links very rare cancer, 9 deaths, to breast implants [STAT]

6.5 Médecines alternatives

Naturopaths cynically use the murder of a quack to promote naturopathic licensure [Restpectful Insolence]

6.6 Publications

Valuing privacy and transparency [ORCID]

On “The Impact Factor Fallacy” [The Scientist]